408 related articles for article (PubMed ID: 18261829)
1. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB.
Barker CJ; Beagley KW; Hafner LM; Timms P
Vaccine; 2008 Mar; 26(10):1285-96. PubMed ID: 18261829
[TBL] [Abstract][Full Text] [Related]
2. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.
Knight SC; Iqball S; Woods C; Stagg A; Ward ME; Tuffrey M
Immunology; 1995 May; 85(1):8-15. PubMed ID: 7543450
[TBL] [Abstract][Full Text] [Related]
3. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans.
Wang J; Zhang Y; Lu C; Lei L; Yu P; Zhong G
J Immunol; 2010 Aug; 185(3):1670-80. PubMed ID: 20581152
[TBL] [Abstract][Full Text] [Related]
4. Identification of immunodominant linear B-cell epitopes within the major outer membrane protein of Chlamydia trachomatis.
Zhu S; Chen J; Zheng M; Gong W; Xue X; Li W; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):771-8. PubMed ID: 20923859
[TBL] [Abstract][Full Text] [Related]
5. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
[TBL] [Abstract][Full Text] [Related]
6. Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections.
Kim SK; Angevine M; Demick K; Ortiz L; Rudersdorf R; Watkins D; DeMars R
J Immunol; 1999 Jun; 162(11):6855-66. PubMed ID: 10352308
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
[TBL] [Abstract][Full Text] [Related]
8. High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge.
Picard MD; Cohane KP; Gierahn TM; Higgins DE; Flechtner JB
Vaccine; 2012 Jun; 30(29):4387-93. PubMed ID: 22682294
[TBL] [Abstract][Full Text] [Related]
9. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
[TBL] [Abstract][Full Text] [Related]
10. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
Tammiruusu A; Haveri A; Pascolo S; Lahesmaa R; Stevanovic S; Rammensee HG; Sarvas M; Puolakkainen M; Vuola JM
Scand J Immunol; 2005 Aug; 62(2):131-9. PubMed ID: 16101819
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis.
Pal S; Peterson EM; de la Maza LM
Vaccine; 2005 Nov; 23(46-47):5351-8. PubMed ID: 16085340
[TBL] [Abstract][Full Text] [Related]
12. The potential for vaccine development against chlamydial infection and disease.
Brunham RC; Zhang DJ; Yang X; McClarty GM
J Infect Dis; 2000 Jun; 181 Suppl 3():S538-43. PubMed ID: 10839755
[TBL] [Abstract][Full Text] [Related]
13. Serological profiling with Chlamycheck, a commercial multiplex recombinant antigen Western blot assay of chlamydial infections.
Radouani F; Maile J; Betsou F
Can J Microbiol; 2007 Dec; 53(12):1360-8. PubMed ID: 18059568
[TBL] [Abstract][Full Text] [Related]
14. Prior exposure to infection with Chlamydia pneumoniae can influence the T-cell-mediated response to Chlamydia trachomatis.
Telyatnikova N; Hill Gaston JS
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):190-8. PubMed ID: 16831205
[TBL] [Abstract][Full Text] [Related]
15. Contemporary approaches to designing and evaluating vaccines against Chlamydia.
Igietseme JU; Eko FO; Black CM
Expert Rev Vaccines; 2003 Feb; 2(1):129-46. PubMed ID: 12901604
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
[TBL] [Abstract][Full Text] [Related]
17. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
Marks E; Verolin M; Stensson A; Lycke N
Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
[TBL] [Abstract][Full Text] [Related]
18. Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis.
Stagg AJ; Elsley WA; Pickett MA; Ward ME; Knight SC
Immunology; 1993 May; 79(1):1-9. PubMed ID: 8099564
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
20. A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.
Li W; Murthy AK; Lanka GK; Chetty SL; Yu JJ; Chambers JP; Zhong G; Forsthuber TG; Guentzel MN; Arulanandam BP
Vaccine; 2013 Nov; 31(48):5722-8. PubMed ID: 24096029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
